Analysis of the TCGA database has shown that several key m6A regulatory factors, such as YTHDF2, METTL3, and FTO, exhibit significant expression differences in NSCLC and are closely associated with clinicopathological features and patient prognosis (181). The gene discussed is FTO; the disease is non-small cell lung carcinoma.